First report of a carbapenem-resistant Serratia sarumanii clinical strain co-harboring blaKPC-2 and blaNDM-1 genes in China
Carbapenem-resistant <i>Enterobacteriaceae</i> (CRE), particularly those co-harboring multiple carbapenemase genes, pose a significant global health threat. However, the coexistence of <i>bla</i> <sub>KPC-2</sub> and <i>bla</i> <sub>NDM-1</sub> in <i>Serratia sarumanii</i> has not been previously reported. This study aims to report and characterize the first carbapenem-resistant <i>S. sarumanii</i> (CRSS) clinical strain MAS3954 in China co-harboring <i>bla</i> <sub>KPC-2</sub> and <i>bla</i> <sub>NDM-1</sub>, focusing on its genetic characteristics, plasmid stability, and transfer potential. Whole-genome analysis revealed that the <i>bla</i> <sub>KPC-2</sub> and <i>bla</i> <sub>NDM-1</sub> were located on two distinct plasmids. Plasmid pMAS3954-KPC (113,856 bp, IncFII/IncFIB) exhibited low similarity (<66%) to known plasmids, indicating a novel fusion event between pKPC-h2 and <i>S. marcescens</i> chromosome, while pMAS3954-NDM (55,235 bp, IncX3) was highly conserved (100% identity/coverage). Conjugation experiments showed that the <i>bla</i> <sub>NDM-1</sub> was transferable, while <i>bla</i> <sub>KPC-2</sub> was not. During 10 days of continuous passage, the genetic context of <i>bla</i> <sub>NDM-1</sub> was gradually excised from the plasmids after the 8th day, whereas they maintained 100% retention for <i>bla</i> <sub>KPC-2</sub>. <i>S. sarumanii</i> MAS3954 was multidrug-resistant (MDR), including carbapenems, β-lactams, β-lactam/β-lactamase inhibitors, trimethoprim-sulfamethoxazole, tetracycline, nitrofurantoin, colistin, and fluoroquinolones, but remained susceptible to certain aminoglycosides and tigecycline. Phylogenomic analysis identified a distinct clade for <i>S. sarumanii</i> MAS3954, diverging notably from other strains. Comparison of resistance genes further highlighted the unique co-harboring of <i>bla</i> <sub>KPC-2</sub> and <i>bla</i> <sub>NDM-1</sub> in MAS3954, absent in other strains. To our knowledge, this study represents the first characterization of clinical <i>S. sarumanii</i> strain co-harboring <i>bla</i> <sub>KPC-2</sub> and <i>bla</i> <sub>NDM-1</sub>. The findings highlight the need for enhanced surveillance and infection control to prevent the spread of these MDR strains in healthcare settings.
Authors
- Duochun Wang (ORCID: https://orcid.org/0000-0003-2372-1532)
- He Gao (ORCID: https://orcid.org/0000-0001-8001-5699)
- Xuemei Bai (ORCID: https://orcid.org/0000-0001-6556-8041)
- Zhiwen Sun (ORCID: https://orcid.org/0000-0001-6325-5500)
- Xiao Liu (ORCID: https://orcid.org/0000-0002-0968-2154)
- Zhen Liu (ORCID: https://orcid.org/0000-0002-5046-7755)
Institutions
- Chinese Academy of Sciences (CN)
- Institute of Microbiology (CN)
- National Institute for Communicable Disease Control and Prevention (CN)
Publication Details
- Journal
- Current Research in Microbial Sciences
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.crmicr.2025.100411
- Citations
- 1
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.59